Home / Resources / Blog / Four Things Every Small Biotech Should Look for in a CRO Partner

The Aperio Blog

Home / Resources / Blog / Four Things Every Small Biotech Should Look for in a CRO Partner

Four Things Every Small Biotech Should Look for in a CRO Partner

Four Things Every Small Biotech Should Look for in a CRO Partner

Cari Kniola
Senior Director, Corporate Strategy
September 13, 2021

Small biotech companies are dominating innovation in the life sciences industry. In 2020, small and mid-sized pharma accounted for 72% of the new molecular entities (NME) approved by the US Food and Drug Administration (FDA). And 2021 is shaping up to show similar results.

Despite their success, small biotechs don’t always get the attention and support they need from the CROs running their trials. Historically, big pharma brings more money to CRO relationships, which means they tend to get more seasoned teams and executive attention.

That can be frustrating for smaller firms, especially if they are only developing a single compound. The success of these projects can make or break the business, which makes their milestones and deadlines strategically critical.

They need to know that their CRO cares about their project’s success as much as they do, and that their team understands the ultimate goals. While big pharma may be focused on regulatory approval and commercial success, small biotechs may have more near term milestones, like securing investment capital, selling the compound mid-development, or getting acquired.

These goals can impact the timeline and planning for a trial and require a CRO team who understands the unique challenges that small firms face in developing a new drug.

How to choose

When vetting CROs, along with validating their clinical expertise, small biotechs should look for research partners who can provide the following:

Consulting support. If the biotech’s team has limited experience planning and managing a trial, they should look for a CRO that will offer guidance and consulting as part of the partnership. That includes helping the biotech team set realistic timelines, enrollment goals and budgets, and to identify opportunities to accelerate progress and/or better manage resources.

They should review the entire trial journey together, to identify critical risk points related to recruiting, study start-up, and database locks, so they can plan accordingly. This early and ongoing support ensures the biotech team has the best strategy in place for success, and risk mitigation plans identified if early goals aren’t met.

Flexibility. Small biotech companies with limited resources need a CRO who is able to adapt the trial in response to their evolving needs. In these environments, every patient is crucial to the study, and every decision must be treated with a sense of urgency to deliver the best results.

For example, if early data suggests the study design needs to be revised, or if company priorities change and timelines need to be re-addressed, the CRO should be able to pivot quickly and offer guidance on the best way forward.

Individual attention. A big CRO has the resources and reach to support dozens of clients simultaneously, which can be a great asset for any life sciences company. However, it can also mean that smaller biotechs may not get the level of attention they need or may suffer from a one-size-fits-all approach to trial management.

Smaller CROs run a select number of trials at a time, allowing them to be more responsive to smaller clients. In these organizations, biotech leaders can expect to have an intimate, dedicated team with experience running trials for smaller organizations. These CRO teams use their experience to provide support and guidance to the biotech teams who might not have the bandwidth or internal background to understand the impact of individual study decisions on the big picture.

Global partners. One of the big concerns with small CROs is that they don’t have teams in every country to run global trials. While it is true that many small CROs are not multi-national companies, most of them have partners in other countries who can operate seamlessly with the home team, delivering the same quality and consistency. It’s a lean organizational model that ensures the CRO can provide a global research experience, with less added cost and overhead.

Choosing the right CRO is vital for ensuring you have the best support, guidance and experts on your team. Making sure a CRO will provide the expertise, flexibility, individualized attention and global reach will put you on the best path to success.

About the Author

Cari Kniola
Senior Director, Corporate Strategy

Cari’s role in Corporate Strategy includes working with the C-Suite in developing and executing strategic corporate development and growth as well as oversight of marketing and proposals.

Cari has nearly 25 years of clinical research experience in both pharmaceutical and medical device studies. During her career she has served in various operations roles, including study coordinator, CRA, clinical trial manager and eight years in project management. Her experience has included roles with sites, sponsors and CROs, and she understands the challenges that each face. For the last several years, Cari’s role has focused on the corporate side of clinical research, using her operations experience and business acumen to drive corporate strategies, marketing, and proposals.

When not planning Aperio’s next move, Cari spends her free time strolling on the Lake Michigan shoreline, hiking in the Indiana Dunes, and fulfilling her obsession with LEGOs.

About Aperio Clinical Outcomes

Aperio Clinical Outcomes provides full, customizable clinical research services across multiple therapeutic areas. Dedicated to transparent interactions with clients, Aperio also offers consulting services in Quality Assurance, Strategic Resourcing, and practical application of the latest Clinical Trial Technology.

In an industry flooded with data, metrics and technology, Aperio remains steadfastly focused on the most important part of the process: people. From start-up to close out and every point in between, Aperio works with its partners to deliver outcomes that will improve patient care and save lives.

Aperio Clinical Outcomes.
We make it clear.

Share this...

You may also like…

Learn how Aperio Clinical Outcomes can help you.
Contact us today.